Protagonist Therapeutics Inc (PTGX) short volume · rev $46.0M
Protagonist Therapeutics Inc FINRA short-volume cache. Latest 2026-10-21.
| Date | Short | Total | Short % |
|---|---|---|---|
| 2026-10-21 | 157,747 | 246,974 | 63.9% |
| 2026-10-20 | 101,552 | 273,935 | 37.1% |
| 2026-10-19 | 150,606 | 233,078 | 64.6% |
| 2026-10-16 | 278,259 | 372,509 | 74.7% |
| 2026-10-15 | 197,370 | 260,725 | 75.7% |
| 2026-10-14 | 150,221 | 191,895 | 78.3% |
| 2026-10-13 | 312,800 | 415,427 | 75.3% |
| 2026-10-12 | 303,169 | 393,839 | 77.0% |
| 2026-10-09 | 311,512 | 388,104 | 80.3% |
| 2026-10-08 | 419,503 | 503,773 | 83.3% |
PTGX short volume FAQ
What was PTGX's latest FINRA short volume?
On Oct 21, 2026, cached FINRA short volume for Protagonist Therapeutics Inc (PTGX) was 157,747 shares, 63.9% of 246,974 total volume.
How many PTGX short-volume sessions are listed on this page?
This page lists 10 cached FINRA short-volume sessions for Protagonist Therapeutics Inc (PTGX), from Oct 8, 2026 through Oct 21, 2026.
How did PTGX short volume percent change from the prior cached session?
Cached FINRA short volume for Protagonist Therapeutics Inc (PTGX) moved from 37.1% on Oct 20, 2026 to 63.9% on Oct 21, 2026, up 26.8 percentage points.
What was the highest PTGX short volume percent on this page?
The highest cached FINRA short volume on this page is 83.3% of total volume on Oct 8, 2026.
Where is PTGX listed?
Protagonist Therapeutics Inc (PTGX) common stock is listed on NASDAQ.
What is PTGX's latest revenue?
Latest cached Protagonist Therapeutics Inc (PTGX) revenue for Dec 31, 2025 was $46.0M. Statements: https://lician.com/financials/ptgx
What is the average PTGX short volume percent on this page?
Across 10 cached sessions on this page, Protagonist Therapeutics Inc (PTGX) short volume averaged 71.0% of total volume.
Where is PTGX short volume listed?
Cached FINRA short volume for Protagonist Therapeutics Inc (PTGX) is listed at https://lician.com/short-interest/ptgx.
Not investment advice. Cached rows, not a live tape.